Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
About a quarter of people taking a higher dose of Ocaliva saw an improvement in liver fibrosis.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
Consistent use of medication-assisted treatment for opioid use disorder can apparently reduce this risk.
HCV incidence in a Canadian study was lower than rates seen in some European countries.
The application is based on study results showing that up to 23% of treated patients saw an improvement in liver fibrosis.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.